BI
BioRem Inc.
BIRMF · OTC
$2.50 +0.00% (+$0.00)
1M -7.41%
Market Cap $57.0M
P/E Ratio 9.16x
Div. Yield -
ROE 41.42%
Bulios Fair Price
$3.03
21.2% upside
Current Price
$2.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BIRMF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
71 /100
Cheap P/FCF 17,068.20x
P/S 1.12x
P/B 3.24x
Growth
94 /100
Growing Rev. growth 13.61%
FCF growth 80.20%
Book val. growth 48.87%
Profitability
49 /100
Moderate Net margin 12.26%
Op. margin 16.44%
FCF margin 0.01%
Quality
100 /100
Excellent ROE 41.42%
ROA 17.44%
Asset turnover 1.42x
Debt
100 /100
Low Current ratio 2.04x
Int. coverage 61.15x
Net debt/EBITDA -0.53x
Stability
75 /100
Stable Rev. volatility 30.88%
EPS volatility 19.73%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIRMF
Online
Sector
Industrials
Industry
Industrial - Pollution & Treatment Controls
CEO
Derek S. Webb
Employees
34
Headquarters
Puslinch
Upcoming events
17 NOV
Earnings
Upcoming earnings report